StockNews.AI
IRTC
StockNews.AI
194 days

iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

1. iRhythm will release Q4 and full year 2024 results on Feb 20. 2. A conference call will follow at 1:30 PM PT for discussion. 3. iRhythm specializes in digital health technologies to predict and prevent disease. 4. The company's focus is on transforming heart data into actionable insights. 5. The results may reflect growth in the digital health sector.

3m saved
Insight
Article

FAQ

Why Neutral?

Earnings reports typically do not guarantee substantial stock movement, as seen with past quarterly results in the healthcare tech sector.

How important is it?

The release of financial results is critical but does not predict clear market direction.

Why Short Term?

The upcoming earnings report may lead to volatility, consistent with previous quarterly fluctuations.

Related Companies

February 06, 2025 16:05 ET  | Source: iRhythm SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the fourth quarter and full year 2024 after the close of trading on Thursday, February 20, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com. About iRhythm Technologies, Inc. iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all. Investor Contact Stephanie Zhadkevich investors@irhythmtech.com Media Contact Kassandra Perryirhythm@highwirepr.com

Related News